← Evidence map

ArticleJournal of translational medicine2016

ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56 dim CD16+ and CD56 bright CD16 dim/- natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.

Teilah Kathryn Huth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

32 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 27098723